The American Academy of HIV Medicine www.aahivm.org
Zolopa 2013
Zolopa A, Sax P, DeJesus E, et al. A randomized double-blind comparison of coformulated elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus favirenz/emtricitabine/tenofovirdisoproxil fumarate for initial treatment of HIV-1 infection: Analysis of Week 96 results. J Acquir Immune Defic Syndr. 2013;63:96-100.
| Type | Journal Article |
|---|---|
| Title | A randomized double-blind comparison of coformulated elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus favirenz/emtricitabine/tenofovirdisoproxil fumarate for initial treatment of HIV-1 infection: Analysis of Week 96 results |
| Source | J Acquir Immune Defic Syndr. 2013;63:96-100 |
| 1st Author | |
| Authors | |
| Year | 2013 |
| Page(s) | 96-100 |
Contact
AAHIVM National Office
1627 Eye St NW Suite 835
Washington, D.C. 20006
About
The American Academy of HIV Medicine is a professional organization that supports the HIV practitioner and promotes accessible, quality care for all Americans living with HIV disease. Our membership of HIV practitioners and credentialed HIV Specialists™, HIV Experts™, and HIV Pharmacists™ provide direct care to the majority of HIV patients in the US.